patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · oligonucleotide
plozasiran sodium
Marketedupdated 2mo agoby $ARWR ARROWHEAD PHARMACEUTICALS, INC.🔗 ChEMBL
Approvedcommunity read0 votes
Oligonucleotide drug with a maximum clinical stage of Unknown (across all indications), with 3 investigational indications.
all catalysts(1)
approval · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that